Seeliger H - Search Results

1

The challenge of pancreatic anastomosis.

Kleespies A, Albertsmeier M, Obeidat F, Seeliger H, Jauch KW, Bruns CJ. Kleespies A, et al. Among authors: seeliger h. Langenbecks Arch Surg. 2008 Jul;393(4):459-71. doi: 10.1007/s00423-008-0324-4. Epub 2008 Apr 1. Langenbecks Arch Surg. 2008. PMID: 18379817 Review.

2

Surgical management of bile duct injuries following laparoscopic cholecystectomy: analysis and follow-up of 28 cases.

Seeliger H, Fürst A, Zülke C, Jauch KW. Seeliger H, et al. Langenbecks Arch Surg. 2002 Nov;387(7-8):286-93. doi: 10.1007/s00423-002-0330-x. Epub 2002 Nov 5. Langenbecks Arch Surg. 2002. PMID: 12447554

3

Minimal residual disease in gastric cancer.

Seeliger H, Spatz H, Jauch KW. Seeliger H, et al. Recent Results Cancer Res. 2003;162:79-87. doi: 10.1007/978-3-642-59349-9_7. Recent Results Cancer Res. 2003. PMID: 12790323 Review.

4

Vascular endothelial growth factor in colorectal cancer.

Guba M, Seeliger H, Kleespies A, Jauch KW, Bruns C. Guba M, et al. Among authors: seeliger h. Int J Colorectal Dis. 2004 Nov;19(6):510-7. doi: 10.1007/s00384-003-0576-y. Epub 2004 Mar 4. Int J Colorectal Dis. 2004. PMID: 14999511 Review.

5

Blockage of 2-deoxy-D-ribose-induced angiogenesis with rapamycin counteracts a thymidine phosphorylase-based escape mechanism available for colon cancer under 5-fluorouracil therapy.

Seeliger H, Guba M, Koehl GE, Doenecke A, Steinbauer M, Bruns CJ, Wagner C, Frank E, Jauch KW, Geissler EK. Seeliger H, et al. Clin Cancer Res. 2004 Mar 1;10(5):1843-52. doi: 10.1158/1078-0432.ccr-1176-3. Clin Cancer Res. 2004. PMID: 15014039

6

Rapamycin-induced endothelial cell death and tumor vessel thrombosis potentiate cytotoxic therapy against pancreatic cancer.

Bruns CJ, Koehl GE, Guba M, Yezhelyev M, Steinbauer M, Seeliger H, Schwend A, Hoehn A, Jauch KW, Geissler EK. Bruns CJ, et al. Among authors: seeliger h. Clin Cancer Res. 2004 Mar 15;10(6):2109-19. doi: 10.1158/1078-0432.ccr-03-0502. Clin Cancer Res. 2004. PMID: 15041732

7

Rapamycin induces tumor-specific thrombosis via tissue factor in the presence of VEGF.

Guba M, Yezhelyev M, Eichhorn ME, Schmid G, Ischenko I, Papyan A, Graeb C, Seeliger H, Geissler EK, Jauch KW, Bruns CJ. Guba M, et al. Among authors: seeliger h. Blood. 2005 Jun 1;105(11):4463-9. doi: 10.1182/blood-2004-09-3540. Epub 2005 Jan 25. Blood. 2005. PMID: 15671443 Free article.

8

Role of mTOR in solid tumor systems: a therapeutical target against primary tumor growth, metastases, and angiogenesis.

Seeliger H, Guba M, Kleespies A, Jauch KW, Bruns CJ. Seeliger H, et al. Cancer Metastasis Rev. 2007 Dec;26(3-4):611-21. doi: 10.1007/s10555-007-9077-8. Cancer Metastasis Rev. 2007. PMID: 17713840 Review.

9

Matuzumab short-term therapy in experimental pancreatic cancer: prolonged antitumor activity in combination with gemcitabine.

Kleespies A, Ischenko I, Eichhorn ME, Seeliger H, Amendt C, Mantell O, Jauch KW, Bruns CJ. Kleespies A, et al. Among authors: seeliger h. Clin Cancer Res. 2008 Sep 1;14(17):5426-36. doi: 10.1158/1078-0432.CCR-07-5245. Clin Cancer Res. 2008. PMID: 18765534

10

Inhibition of Src tyrosine kinase reverts chemoresistance toward 5-fluorouracil in human pancreatic carcinoma cells: an involvement of epidermal growth factor receptor signaling.

Ischenko I, Camaj P, Seeliger H, Kleespies A, Guba M, De Toni EN, Schwarz B, Graeb C, Eichhorn ME, Jauch KW, Bruns CJ. Ischenko I, et al. Among authors: seeliger h. Oncogene. 2008 Dec 4;27(57):7212-22. doi: 10.1038/onc.2008.326. Epub 2008 Sep 15. Oncogene. 2008. PMID: 18794807

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

347 results

Search Page

Filters